The Chronic Lymphocytic Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
BSH 2017 | How can doctors discuss CLL treatment options with patients?
Clemens Wendtner, MD from the University of Cologne, Cologne, Germany, advises doctors on how to discuss different treatment options with chronic lymphocytic leukemia (CLL) patients at the British Society for Haematology (BSH) Annual Scientific Meeting in 2017 in Brighton, UK. He highlights the value of calming patients by pointing out that a number of choices are available, but speaks about the importance of patience, as not all CLL patients need to be treated.
